Pharmaceutical composition for treating fatty liver, and traditional Chinese medicine preparation thereof

Abstract

The invention discloses a pharmaceutical composition for treating fatty liver. Effective ingredients of the pharmaceutical composition comprise one selected from raw hawthorn, cassia seed and bushy knotweed rhizome, or a mixture of more than one of the above. A weight proportion of raw hawthorn is 3-50; a weight proportion of cassia seed is 2-50; and a weight proportion of bushy knotweed rhizome is 5-40. The invention also discloses a traditional Chinese medicine preparation containing the pharmaceutical composition. The traditional Chinese medicine preparation may be any one of medicinal tea, water decoction, granules, powder, injection, patches, ointment, tablets and pills. The traditional Chinese medicine preparation is an ancillary drug for treating the fatty liver by acupuncture and moxibustion therapy. The pharmaceutical composition provided by the invention is cheap, and has a definite therapeutic effect and good security. By combining the traditional Chinese medicine preparation and the acupuncture and moxibustion therapy to treat the fatty liver, a stable and definite curative effect can be achieved; the method is simple; and normalization is easy to form. The traditional Chinese medicine preparation is convenient for normalized implementation and popularization in various hospitals, particularly community hospitals, thereby providing cheap, convenient, simple and effective medical services for the majority of patients.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating fatty liver disease. Background technique [0002] Fatty liver refers to the lesion of excessive accumulation of fat in liver cells due to various reasons. Due to the inability to carry out normal fat metabolism, lipids, especially neutral fat (triglycerides) accumulate excessively in the liver , a disease of adipocytes observed in more than half of the hepatocytes. Fatty liver disease is a serious threat to the health of Chinese people, becoming the second largest liver disease after viral hepatitis, and has been recognized as a common cause of hidden cirrhosis. Fatty liver can be subdivided into obesity fatty liver, alcoholic fatty liver, malnutrition fatty liver, diabetic fatty liver, drug-induced fatty liver, fatty liver of pregnancy and such as combination, bacterial pneumonia or sepsis according to the cau...

AI Technical Summary

Problems solved by technology

However, the above-mentioned method is expensive and difficult to extract, which limits the wide use of the above-mentioned drugs.

[0006] In addition, Western medicine or surgical treatment cannot achieve health care for the human liver. Because fatty liver has no obvious symptoms in the early stage, it is easy to be ignored. When the liver has obvious lesions, fatty liver is generally more serious, so it is easy to miss the best treatment. Time, so that the patient's condition worsened or developed into liver cirrhosis, liver cancer, etc.

Even if fatty liver is detected in time, the treatment method will cause great harm to fatty liver patients and the treatment cost is expensive. Medical resources are concentrated in large hospitals, and it is impossible to go deep into hospitals at all levels, especially community hospitals, and it is impossible for the majority of patients to receive effective treatment.